A novel strategy using single-chain antibody to show the importance of Bcl-2 in mast cell survival

Area of Science:

• Cell biology
• Molecular biology
• Immunology

Background:

• Apoptosis, or programmed cell death, is crucial for physiological processes and is regulated by Bcl-2 family proteins.
• The specific role of Bcl-2 proteins in mast cell apoptosis remains unclear.
• Bcl-2 proteins act as critical regulators, with both proapoptotic and antiapoptotic members influencing cell fate.

Purpose of the Study:

• To investigate the role of Bcl-2 in mast cell apoptosis.
• To develop and characterize a novel anti-Bcl-2 single-chain variable fragment (scFv) capable of intracellular targeting.
• To assess the efficacy of the anti-Bcl-2 scFv in neutralizing Bcl-2 and affecting apoptosis in mast cells and cancer cells.

Main Methods:

• Generation of a semisynthetic human phage-display antibody library to raise an antibody against Bcl-2.
• Engineering the anti-Bcl-2 scFv with a TAT sequence for cell membrane translocation.
• Testing the intracellular neutralization of Bcl-2 and its impact on apoptosis in mast cells and a human breast cancer cell line.

Main Results:

• A functional anti-Bcl-2 single-chain antibody fragment (scFv) was successfully developed.
• The TAT-conjugated anti-Bcl-2 scFv demonstrated the ability to penetrate living cells and neutralize Bcl-2 intracellularly.
• The antibody specifically bound to the BH1 domain of Bcl-2, eradicating its antiapoptotic function in mast cells and a breast cancer cell line.

Conclusions:

• The developed anti-Bcl-2 scFv is a potent inhibitor of Bcl-2's antiapoptotic activity.
• This targeted intracellular neutralization offers a potential therapeutic strategy for conditions involving aberrant cell survival, such as in certain cancers.
• The study clarifies the involvement of Bcl-2 in mast cell apoptosis and provides a tool for further investigation.